Chemical modifications and bioconjugate reactions of nanomaterials for sensing, imaging, drug delivery and therapy
Abstract
As prepared nanomaterials of metals, semiconductors, polymers and carbon often need surface modifications such as ligand exchange, and chemical and bioconjugate reactions for various biosensor, bioanalytical, bioimaging, drug delivery and therapeutic applications. Such surface modifications help us to control the physico-chemical, toxicological and pharmacological properties of nanomaterials. Furthermore, introduction of various reactive functional groups on the surface of nanomaterials allows us to conjugate a spectrum of contrast agents, antibodies, peptides, ligands, drugs and genes, and construct multifunctional and hybrid nanomaterials for the targeted imaging and treatment of cancers. This tutorial review is intended to provide an introduction to newcomers about how chemical and bioconjugate reactions transform the surface of nanomaterials such as silica nanoparticles, gold nanoparticles, gold quantum clusters, semiconductor quantum dots, carbon nanotubes, fullerene and graphene, and accordingly formulate them for applications such as biosensing, bioimaging, drug and gene delivery, chemotherapy, photodynamic therapy and photothermal therapy. Nonetheless, controversial reports and our growing concerns about toxicity and pharmacokinetics of nanomaterials suggest the need for not only rigorous in vivo experiments in animal models but also novel nanomaterials for practical applications in the clinical settings. Further reading of original and review articles cited herein is necessary to buildup in-depth knowledge about the chemistry, bioconjugate chemistry and biological applications of individual nanomaterials.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Nanoparticles have substantial surface area-to-volume ratios, making them ideal for drug modification or attachment of detection probes.
“They also have substantial surface area-to-volume ratios, which makes them ideal for drug modification or attachment of detection probes [32–34].”
From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [32]
The citation lists haven’t been fetched yet
References 49 · Cited by 1,186
- Authors
- Biju, V.
- Affiliations
- Japan Science and Technology Agency (JP)
- Corresponding author
- Biju, Vasudevanpillai
- Venue
- Chem. Soc. Rev.
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2014
- Volume
- 43
- Issue
- 3
- Pages
- 744-764
- ISSN
- 0306-0012 (ISSN-L)
- 1460-4744
- OpenAlex
- W1976278209
- Cited by
- 1,186
- References
- 49
- Citations by year
- 2026: 38 · 2025: 56 · 2024: 80 · 2023: 75 · 2022: 96 · 2021: 92 · 2020: 129 · 2019: 115 · 2018: 121 · 2017: 104 · 2016: 113 · 2015: 110 · 2014: 55 · 2013: 1
- FWCI
- 8.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Chemical Society Reviews (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (24750029)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Engineering › Biomedical Engineering › Nanotechnology research and applications
- Keywords
- nanomaterial surface modification, bioconjugation, ligand exchange, silica nanoparticles, gold nanoparticles, semiconductor quantum dots, carbon nanotubes, C60, graphene, biosensing, bioimaging, drug delivery, gene delivery, photodynamic therapy, photothermal therapy, cancer theranostics, nanomaterial toxicity, pharmacokinetics
- MeSH terms
- Animals, Antibodies, Antineoplastic Agents, Contrast Media, Drug Carriers, Humans, Magnetic Resonance Imaging, Neoplasms, Peptides, Nanostructures
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review